HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Comparison between the angiotensin II receptor antagonist candesartan cilexetil and the angiotensin-converting enzyme inhibitor trandolapril in microalbuminuria of patients with early diabetic nephropathy.

AuthorsT Nakamura, C Ushiyama, S Suzuki, N Shimada, K Sekizuka, I Ebihara, Y Takahashi, A Tanaka, H Koide
JournalNephron (Nephron) Vol. 86 Issue 2 Pg. 247 (Oct 2000) ISSN: 1660-8151 [Print] Switzerland
PMID11015024 (Publication Type: Clinical Trial, Comparative Study, Letter, Multicenter Study, Randomized Controlled Trial)
Chemical References
  • Angiotensin Receptor Antagonists
  • Angiotensin-Converting Enzyme Inhibitors
  • Antihypertensive Agents
  • Benzimidazoles
  • Biphenyl Compounds
  • Indoles
  • Prodrugs
  • Tetrazoles
  • trandolapril
  • candesartan cilexetil
Topics
  • Albuminuria
  • Angiotensin Receptor Antagonists
  • Angiotensin-Converting Enzyme Inhibitors (therapeutic use)
  • Antihypertensive Agents (therapeutic use)
  • Benzimidazoles (therapeutic use)
  • Biphenyl Compounds (therapeutic use)
  • Blood Pressure (drug effects)
  • Diabetic Nephropathies (drug therapy, physiopathology, urine)
  • Female
  • Humans
  • Indoles (therapeutic use)
  • Male
  • Middle Aged
  • Prodrugs (therapeutic use)
  • Tetrazoles

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: